Articles from Impulse Dynamics

CCM therapy is now indicated for symptomatic heart failure patients with diastolic or systolic ventricular dysfunction, offering a broader range of patients a new option for improving quality of life and reducing heart failure hospitalization

Extensive depth of experience comes with new leaders – Chief Operating Officer, Chief Financial Officer, Chief Administrative Officer and Chief Science and Strategy Officer

Milestone Highlights Transformative Symptom Management for Patients Living with Heart Failure

Continued Progress Earns Financing to Accelerate Commercial Growth and Advancing Pipeline

Reflecting Company Commitment to Innovation in Support of Patient Need

Jason Spees Appointed to Chief Executive Officer — Shlomi Nachman To Be Chairman and John Liddicoat To Join the Board of Directors — Expanding Depth of Medical Device Industry Leadership and Track Record of Driving Commercialization Success With Advanced Technology

World’s First Device Combining CCM Therapy With an ICD in a Single Rechargeable Implant That Treats Both Heart Failure Symptoms and Sudden Cardiac Death

Momentum Continues as Depth of Clinical Experience Expands Worldwide

Experience Continues to Show CCM Therapy Addresses Clinical Need in Treating Heart Failure